Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that...
07 Nov, 2025 | 04:11pm • Source: BSE
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider...
30 Oct, 2025 | 06:28pm • Source: BSE
PFA
08 Oct, 2025 | 08:05pm • Source: BSE
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for...
25 Aug, 2025 | 04:50pm • Source: BSE
PFA
23 Jul, 2025 | 05:01pm • Source: BSE
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that...
23 Jul, 2025 | 04:47pm • Source: BSE
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider...
16 Jul, 2025 | 05:18pm • Source: BSE
PFA
04 Jul, 2025 | 05:54pm • Source: BSE
This is to inform you that Outcome of the Board Meeting of the Company held on Friday 23rd May, 2025 in accordance with SEBl (Listing...
23 May, 2025 | 05:35pm • Source: BSE